论文部分内容阅读
抵抗素(resistin)是2001年由Steppan等〔1〕发现的一种新的脂肪细胞因子,可作用于肝脏、脂肪等胰岛素靶器官,通过影响胰岛素信号的转导及代谢相关酶的转录而影响糖、脂代谢,参与机体的能量调节。非酒精性脂肪肝病(nonalcoholic
Resistin is a new adipocytokin discovered by Steppan et al [1] in 2001 and can act on insulin target organs such as the liver and fat and affect insulin signaling and the transcription of metabolism-related enzymes Sugar, lipid metabolism, involved in the body’s energy regulation. Nonalcoholic fatty liver disease